Tim Miller, Forge Biologics CEO

CNS-fo­cused gene ther­a­py biotech forges man­u­fac­tur­ing deal for hear­ing loss drug

A grow­ing gene ther­a­py com­pa­ny is team­ing up with one of the largest gene ther­a­py man­u­fac­tur­ers to get its drug in­to pa­tients in clin­i­cal tri­als …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.